NCT07108166
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
StatusActive, Not Recruiting
PhaseNot applicable
SponsorPhilip Morris Products S.A.
Primary completion (estimated)
At risk: Primary completion moved at least 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 10 words Show 4 more changesShow less
- Primary completion pushed from Aug 2026 to Feb 2027
- Study completion pushed from Nov 2026 to Jun 2027
- Secondary endpoints: details revised at 4 of 13 entries
- Site details revised at 11 of 112 sites
- Minor Enrollment closed, study ongoing
- Site details revised at 112 of 112 sites
- Notable Trial status changed: Active, Not Recruiting → Recruiting
- Site details revised at 112 of 112 sites
- Minor Trial status: Recruiting to Active, Not Recruiting
- Study sites: 111 to 112
- Notable Eligibility criteria expanded, about 29 words
- Secondary endpoints: details revised at 13 of 13 entries
Show 3 earlier versionsHide 3 earlier versions
- Minor Study sites: 92 to 111v4
- Minor Study sites: 64 to 92v3
- Minor Study sites: 77 to 64v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Reduction in 24-hour cough frequency
Timeframe: Measured from start of product use to end of week 24 (end of the exposure period).
Secondary (13)
Changes in lung function (from Baseline in FEV1 post-bronchodilator)
Changes in the 24-hour cough frequency over time
Percentage of patients with a change in 24-hour cough frequency over time
Changes in the Cough Quality of Life Questionnaire (CQLQ) on chronic cough
Changes in cough severity over time
Show 8 moreShow less
Changes in bronchial hyperresponsiveness (BHR) mannitol test over time
Impact of COPD (cough, sputum, dyspnea, chest tightness) on health status
Changes in shortness of breath assessed over time
Changes in functional capacity over time
Changes in exposure to carbon monoxide over time
Changes in self-reported tobacco and nicotine containing product consumption
Changes in nicotine exposure levels
Changes in acrylonitrile exposure levels
Arms and interventions
CigaretteActive comparator
THSActive comparator
Other: Cigarette, THS
Sites
112 sites in 9 countries
United States 46, Germany 14, United Kingdom 10, Japan 9, Poland 9, Romania 7, Bulgaria 6, Czechia 6, Slovakia 5